NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancerBérengère Salomé, Nina Bhardwaj, John P. Sfakianos et al.|Cancer Cell|2022Cited by 127
HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker studyVivek Naranbhai, Mary Carrington, Toni K. Choueiri et al.|The Lancet Oncology|2021Cited by 126
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative ColitisMartin E. Baumdick, Tariq Ahmad, Annika Niehrs et al.|Gastroenterology|2023Cited by 19
Immunopeptidomics can inform the design of mRNA vaccines for the delivery of <i>Mycobacterium tuberculosis</i> MHC class II antigensOwen Leddy, Bryan D. Bryson, Paul Ogongo et al.|Science Translational Medicine|2025Cited by 9
Targeting infection-specific peptides in immunopeptidomics studies for vaccine target discoveryOwen Leddy, Forest M. White, Yuko Yuki et al.|The Journal of Experimental Medicine|2025Cited by 6